Rede Wealth, LLC Abb Vie Inc. Transaction History

Rede Wealth, LLC

$238 Million
Q1 2024

A detailed history of Rede Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Rede Wealth, LLC holds 1,871 shares of ABBV stock, worth $312,924. This represents 0.14% of its overall portfolio holdings.

Number of Shares

1,871

Previous 1,645 13.74%

Holding current value

$312,924

Previous $254,000 33.86%

% of portfolio

0.14%

Previous 0.12%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$159.82 - $182.1 $36,119 - $41,154	226 Added 13.74%	1,871 $340,000
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $688 - $774	5 Added 0.3%	1,645 $254,000
Q3 2023 Nov 08, 2023	SELL	$133.59 - $154.65 $109,543 - $126,813	-820 Reduced 33.33%	1,640 $244,000
Q2 2023 Aug 07, 2023	BUY	$132.51 - $164.9 $3,842 - $4,782	29 Added 1.19%	2,460 $331,000
Q1 2023 Apr 26, 2023	BUY	$144.61 - $166.54 $3,470 - $3,996	24 Added 1.0%	2,431 $387,000

Q4 2022 Jan 17, 2023	SELL	$138.31 - $165.87 $11,894 - $14,264	-86 Reduced 3.45%	2,407 $0
Q3 2022 Oct 17, 2022	SELL	$134.21 - $153.93 $1,342 - $1,539	-10 Reduced 0.4%	2,493 $335,000
Q2 2022 Jul 21, 2022	BUY	$137.62 - $174.96 $137 - $174	1 Added 0.04%	2,503 $383,000
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $54,574 - $69,052	-508 Reduced 16.88%	2,502 $339,000
Q3 2021 Oct 08, 2021	BUY	$106.4 - $120.78 $54,689 - $62,080	514 Added 20.59%	3,010 $324,000
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $21,147 - $23,559	201 Added 8.76%	2,496 $252,000
Q1 2021 May 12, 2021	BUY	$102.3 - $112.62 $27,927 - $30,745	273 Added 13.5%	2,295 $249,000
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $162,750 - $219,730	2,022 New	2,022 $218,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rede Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rede Wealth, LLC with notifications on news.

Account